The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
By J. Yepes‐Nuñez, G. Úrrutia, Marta Romero-García, S. Alonso-Fernández. Revista Española de Cardiología, 2021
6,153 citations recorded by the source corpus.
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. Full English text available from:www.revespcardiol.org/en.
Subfields: Public Health, Environmental and Occupational Health, Sociology and Political Science, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/3ad641921dbb490bc8c60866d55a6b0f20e9317b
Citations in the corpus
- Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (2020, neutral): “Furthermore, as we have emphasized in the statement paper (45) and explanation and elaboration paper (48), we do not expect authors to address each PRISMA 2020 item within the main report of the review; referring to relevant information in publicly accessible protocols or supplementary files may suf”
- Aperiodic and Hurst EEG exponents across early human brain development: A systematic review (2024, unknown): “The systematic review was completed according to the PRISMA guidelines (Page et al., 2021) and pre-registered with the international Prospective Register of Systematic Reviews (PROSPERO Registration number: CRD42023363294).”